ARCH Venture Partners — 2025 Investments
7 investments dated 2025 · listed companies and verified rows first · show all
Basking Biosciences develops therapeutics for thrombosis, vascular biology, and ischemic disease.
BiotechDigital HealthHealthtechMedical DevicesCary, US
Shahid Nimjee(Co-founder, Chief Scientific Officer and Stroke Clinical Lead)inBruce Sullenger(Co-founder)Julia Owens(Executive Officer, Director, Promoter)Ryan Helon(Director)Dan Myers(Director)Richard Shea(Executive Officer, Director, Promoter)
Board seatSteve Gillis· per SEC Form D
Areteia Therapeutics was a clinical-stage biotechnology company that is no longer operating.
BiotechChapel Hill, US
Robin Walker(Executive Officer)Christopher Courts(Executive Officer)Jorge Bartolome(Executive Officer, Director)
BoardBenjamin Gomez(Director)Adam Koppel(Director)Michael E. Bozik(Director)
Board seatPaul Berns· per SEC Form D
HealthtechMenlo Park, US
William Hagstrom(Executive Officer, Director)Melinda Thomas(Executive Officer)Mark Weeks(Executive Officer)Thomas Hawes(Director)A. Grant Heidrich III(Director)Andrea Jackson(Director)
Board seatGeorge Scangos· per SEC Form D · $53.7M raise · filed Mar 2025
Pheast Therapeutics develops immunotherapies targeting cancer, building on foundational research from Stanford's stem cell research institute.
BiotechHealthtechMedical DevicesRedwood City, US
Irv Weissman(Cofounder, Scientific Advisor, Board Director)Ravi Majeti(Cofounder, Scientific Advisor, Board Observer)Amira Barkal(Principal Founder, Scientific Advisor, Board Director)Roy Maute(Cofounder & Chief Executive Officer)
BoardJacob Vogelstein(Director)
Board seatSteven Gillis· per SEC Form D
BiotechSeattle, US
CHRISTOPHER TOOMBS(Executive Officer)LINDSAY RAYLE(Executive Officer, Promoter)Asish Xavier(Director)M. Johnston Erwin(Director)David Schubert(Executive Officer, Promoter)Joel Marcus(Director)
Board seatSteven Gillis· per SEC Form D · $12.2M raise · filed Jan 2025
Rezo Therapeutics is a drug discovery and development company focused on oncology and inflammation therapeutic areas.
AI & Machine LearningBiotechDeep TechSan Francisco, US
Nevan Krogan(Co-Founder)Sourav Bandyopadhyay(Co-Founder)Norbert Bischofberger(Co-Founder)Natalia Jura(Co-Founder)George Scangos(Co-Founder)Kevan Shokat(Co-Founder)
Board seatGeorge Scangos· per SEC Form D · $80.1M raise · filed Aug 2025
Treeline develops therapeutics focused on oncology, leveraging insights from clinical practice and laboratory research.
AI & Machine LearningBiotechMedical DevicesWatertown, US
Joshua H. Bilenker(Executive Officer, Director, Promoter)Jeffrey Engelman(Executive Officer, Director, Promoter)
BoardAli Satvat(Director)David Schenkein(Director)Steven Elms(Director)
Board seatKristina Burow· per SEC Form D
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.